cladribine has been researched along with Enteropathy-Associated T-Cell Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allez, M; Amiot, A; Bouhnik, Y; Fieschi, C; Galicier, L; Gornet, JM; Joly, F; LĂ©mann, M; Oksenhendler, E; Treton, X | 1 |
1 other study(ies) available for cladribine and Enteropathy-Associated T-Cell Lymphoma
Article | Year |
---|---|
High frequency of fatal haemophagocytic lymphohistiocytosis syndrome in enteropathy-associated T cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Disease Progression; Disease-Free Survival; Enteropathy-Associated T-Cell Lymphoma; Female; Humans; Kaplan-Meier Estimate; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Neutropenia; Purine Nucleotides; Retrospective Studies | 2012 |